Delivery Order SPE2DR25D3103-SPE2DR26F9J33
Award Date 11/24/25
Potential Completion Date 11/25/25
Potential Value $3.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Deferasirox 360 mg tablets (30-count packages) under a firm fixed-price contract valued at $22,697.07, with an ultimate completion date of December 11, 2025. This non-set-aside delivery order represents a competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor, reflecting the agency's ongoing procurement of specialized pharmaceuticals to support military and federal...
- The Defense Logistics Agency awarded a delivery order valued at $32,834.44 to AmerisourceBergen Drug Corp for the supply of Deferasirox 360 mg tablets (30-count units) with a completion date of December 4, 2025. The award, issued on December 3, 2025, utilized firm fixed pricing with no set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed this delivery order from its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Deferasirox 360 mg tablets (30-count) with a ceiling value of $48,938.95. This firm fixed-price delivery order, issued on December 2, 2025, with an ultimate completion date of December 3, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Deferasirox 360 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $28,655.27 and an ultimate completion date of October 28, 2025. The contract involves no set-aside designation, meaning it was competitively awarded. The place of performance is listed as AmerisourceBergen's Corporate Office location in Conshohocken,...
- The Defense Logistics Agency awarded a $49,888.19 delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Deferasirox 360 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price contract contains no set-aside designation and is scheduled for completion by December 10, 2025. The pharmaceutical will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the pharmaceutical product Deferasirox 500 mg tablets for suspension. The contract has a ceiling value of $2,455.30 and a period of performance through March 21, 2024. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the prime contractor on this delivery order, which is issued under a larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 360 mg Deferasirox tablets (30-count units) on May 16, 2025, with a ceiling value of $5,673.37 and an ultimate completion date of May 19, 2025. This is a firm fixed-price delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The award represents a competitive, non-set-aside...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 25, 2025, for Deferasirox 360 mg tablets in quantities of 30 tablets. This firm fixed price delivery order, valued at $9,492.73, was competitively awarded without a set-aside designation and carries an ultimate completion date of August 26, 2025. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,882.12 to AmerisourceBergen Drug Corp for the supply of Deferasirox 360 mg tablets (30-count) on December 1, 2025, with completion scheduled for December 2, 2025. This firm fixed-price, non-set-aside contract was issued as a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling through December 2026....
- This is a $55,877.06 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 360 mg Deferasirox tablets, a medication used to treat chronic iron overload. The award has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...